HPRA Drug Safety Newsletter Edition 95
Download:
hpra-drug-safety-newsletter-edition-95.pdf
282 KB
The latest edition of the HPRA Drug Safety Newsletter (DSN) includes important updates to support the safe and appropriate use of the following medicines:
Methotrexate – New measures to avoid dosing errors
SGLT2 inhibitors – Updated advice on monitoring ketone bodies in patients hospitalised for major surgical procedures or acute serious medical illnesses
Ingenol mebutate (Picato▼) – Use with caution in patients with a history of skin cancer
Fingolimod (Gilenya▼) – Contraindication in pregnant women and in women of child bearing potential not using effective contraception
Levothyroxine – Close monitoring recommended in the event of a brand change
Parenteral nutrition products for neonates and children below 2 years of age – Protect from light until administration is completed
« Back